Suppr超能文献

相似文献

1
Transplantation in the nonhuman primate MPTP model of Parkinson's disease: update and perspectives.
Primate Biol. 2017 Oct 11;4(2):185-213. doi: 10.5194/pb-4-185-2017. eCollection 2017.
3
Stem cell therapy for Parkinson's disease using non-human primate models.
Zool Res. 2019 Sep 18;40(5):349-357. doi: 10.24272/j.issn.2095-8137.2019.053.
6
Nonhuman primate model in clinical modeling of diseases for stem cell therapy.
Brain Circ. 2016 Jul-Sep;2(3):141-145. doi: 10.4103/2394-8108.192524. Epub 2016 Oct 18.
7
Nonhuman primate models of Parkinson's disease.
ILAR J. 2007;48(4):339-55. doi: 10.1093/ilar.48.4.339.
8
The role of nonhuman primate models in the development of cell-based therapies for Parkinson's disease.
J Neural Transm (Vienna). 2018 Mar;125(3):365-384. doi: 10.1007/s00702-017-1708-9. Epub 2017 Mar 22.
9
Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson's disease.
Stem Cell Res. 2016 Sep;17(2):352-366. doi: 10.1016/j.scr.2016.08.013. Epub 2016 Aug 26.
10
The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future.
Prog Brain Res. 2010;184:133-57. doi: 10.1016/S0079-6123(10)84007-5.

引用本文的文献

1
Genetically engineered mesenchymal stem cells with dopamine synthesis for Parkinson's disease in animal models.
NPJ Parkinsons Dis. 2022 Dec 22;8(1):175. doi: 10.1038/s41531-022-00440-6.
2
Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson's disease.
NPJ Regen Med. 2022 Apr 21;7(1):24. doi: 10.1038/s41536-022-00221-y.
4
Modeling Parkinson's Disease: Not Only Rodents?
Front Aging Neurosci. 2021 Aug 6;13:695718. doi: 10.3389/fnagi.2021.695718. eCollection 2021.

本文引用的文献

1
Strategies for bringing stem cell-derived dopamine neurons to the clinic: A European approach (STEM-PD).
Prog Brain Res. 2017;230:165-190. doi: 10.1016/bs.pbr.2016.11.011. Epub 2017 Feb 7.
2
Biomaterials and cells for neural tissue engineering: Current choices.
Mater Sci Eng C Mater Biol Appl. 2017 Aug 1;77:1302-1315. doi: 10.1016/j.msec.2017.03.264. Epub 2017 Mar 30.
3
α-Synuclein nonhuman primate models of Parkinson's disease.
J Neural Transm (Vienna). 2018 Mar;125(3):385-400. doi: 10.1007/s00702-017-1720-0. Epub 2017 Apr 22.
5
Detecting senescence: a new method for an old pigment.
Aging Cell. 2017 Jun;16(3):432-434. doi: 10.1111/acel.12580. Epub 2017 Feb 9.
6
Differential behavioral outcomes following neonatal versus fetal human retinal pigment epithelial cell striatal implants in parkinsonian rats.
J Neural Transm (Vienna). 2017 Apr;124(4):455-462. doi: 10.1007/s00702-017-1683-1. Epub 2017 Feb 4.
7
Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's Disease.
Cell Stem Cell. 2017 Jan 5;20(1):135-148. doi: 10.1016/j.stem.2016.09.004. Epub 2016 Oct 27.
8
Parkinson's Disease and Cognitive Impairment.
Parkinsons Dis. 2016;2016:6734678. doi: 10.1155/2016/6734678. Epub 2016 Dec 12.
9
Molecular Diversity of Midbrain Development in Mouse, Human, and Stem Cells.
Cell. 2016 Oct 6;167(2):566-580.e19. doi: 10.1016/j.cell.2016.09.027.
10
Development of Bioresorbable Hydrophilic-Hydrophobic Electrospun Scaffolds for Neural Tissue Engineering.
Biomacromolecules. 2016 Oct 10;17(10):3172-3187. doi: 10.1021/acs.biomac.6b00820. Epub 2016 Sep 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验